LogicBio Therapeutics, Inc. (LOGC) Social Stream



LogicBio Therapeutics, Inc. (LOGC): $0.62

-0.05 (-8.08%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

LogicBio Therapeutics Inc (LOGC) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering LogicBio Therapeutics Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-11 5 $20.001 $15 $17.5 $0.7 2400%
2021-11-19 6 $20.001 $8 $15 $0.7 2042.86%
2021-12-26 6 $16 $8 $14.2 $0.7 1928.57%
2022-02-02 5 $16 $6 $11.5 $0.7 1542.86%

The Trend in the Analyst Price Target


Over the past 39 weeks, LOGC's average price target has gone down $8.05.

Over the past 47 weeks, LOGC's average upside potential has been 506.69%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-08 2 24 17 20.25 4.83 319.25%
2021-07-03 5 24 15 19.00 4.32 339.81%
2021-07-06 5 24 15 19.00 4.17 355.64%
2021-09-20 4 24 15 18.80 4.43 324.38%
2021-12-26 6 16 8 14.20 2.47 474.9%

LOGC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.4 4 0 1 0 0 5

The Trend in the Broker Recommendations


LOGC's average broker recommendation rating improved by 0.2 over the prior 35 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, LogicBio Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 698.89% of them.
  • LOGC has a higher average analyst price target than 107.07% of all US stocks.
  • In terms of how LogicBio Therapeutics Inc fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than -283.77% of that group.
  • LogicBio Therapeutics Inc's number of analysts covering the stock is greater than 433.85% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to LogicBio Therapeutics Inc are LJPC, LIFE, and LCTX.

Is LOGC a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6231 seconds.